Current Status and Feasibility of Endoscopic Full‐thickness Resection in Japan: Results of a Questionnaire Survey
Yorimasa Yamamoto,Noriya Uedo,Nobutsugu Abe,Hideki Mori,Haruo Ikeda,Hiromitsu Kanzaki,Kingo Hirasawa,Naohiro Yoshida,Osamu Goto,Shuko Morita,Ping‐Hong Zhou
DOI: https://doi.org/10.1111/den.13045
2018-01-01
Digestive Endoscopy
Abstract:Digestive EndoscopyVolume 30, Issue S1 p. 2-6 EditorialFree Access Current status and feasibility of endoscopic full-thickness resection in Japan: Results of a questionnaire survey Yorimasa Yamamoto, Yorimasa Yamamoto Division of Gastroenterology, Showa University Fujigaoka Hospital, Yokohama, JapanSearch for more papers by this authorNoriya Uedo, Noriya Uedo Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, JapanSearch for more papers by this authorNobutsugu Abe, Nobutsugu Abe Department of Surgery, Kyorin University School of Medicine, Tokyo, JapanSearch for more papers by this authorHirohito Mori, Hirohito Mori Faculty of Medicine, Department of Gastroenterology and Neurology, Kagawa University, Kagawa, JapanSearch for more papers by this authorHaruo Ikeda, Haruo Ikeda Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo, JapanSearch for more papers by this authorHiromitsu Kanzaki, Hiromitsu Kanzaki Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanSearch for more papers by this authorKingo Hirasawa, Kingo Hirasawa Endoscopy Department, Yokohama City University Medical Center, Yokohama, JapanSearch for more papers by this authorNaohiro Yoshida, Naohiro Yoshida Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, JapanSearch for more papers by this authorOsamu Goto, Osamu Goto Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, JapanSearch for more papers by this authorShuko Morita, Shuko Morita Department of Gastroenterology, Kobe City Medical Center General Hospital, Hyogo, JapanSearch for more papers by this authorPinghong Zhou, Pinghong Zhou Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this author Yorimasa Yamamoto, Yorimasa Yamamoto Division of Gastroenterology, Showa University Fujigaoka Hospital, Yokohama, JapanSearch for more papers by this authorNoriya Uedo, Noriya Uedo Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, JapanSearch for more papers by this authorNobutsugu Abe, Nobutsugu Abe Department of Surgery, Kyorin University School of Medicine, Tokyo, JapanSearch for more papers by this authorHirohito Mori, Hirohito Mori Faculty of Medicine, Department of Gastroenterology and Neurology, Kagawa University, Kagawa, JapanSearch for more papers by this authorHaruo Ikeda, Haruo Ikeda Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo, JapanSearch for more papers by this authorHiromitsu Kanzaki, Hiromitsu Kanzaki Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanSearch for more papers by this authorKingo Hirasawa, Kingo Hirasawa Endoscopy Department, Yokohama City University Medical Center, Yokohama, JapanSearch for more papers by this authorNaohiro Yoshida, Naohiro Yoshida Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, JapanSearch for more papers by this authorOsamu Goto, Osamu Goto Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, JapanSearch for more papers by this authorShuko Morita, Shuko Morita Department of Gastroenterology, Kobe City Medical Center General Hospital, Hyogo, JapanSearch for more papers by this authorPinghong Zhou, Pinghong Zhou Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaSearch for more papers by this author First published: 16 April 2018 https://doi.org/10.1111/den.13045Citations: 10AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Introduction Endoscopic submucosal dissection (ESD) has been widely carried out for the treatment of gastrointestinal tract cancers as a minimally invasive treatment. The technique removes the mucosa and the submucosa including the superficial neoplasm. ESD was first applied to early gastric cancer in Japan and now it is carried out worldwide for superficial epithelial neoplasm in the digestive tract. Recently, the technique of ESD has been expanded to new techniques that remove the gastrointestinal wall such as laparoscopy and endoscopy cooperative surgery (LECS) which uses a peroral flexible endoscope to cut the gastrointestinal wall and laparoscopy to close the defect,1 and endoscopic full-thickness resection (EFTR) which uses peroral flexible endoscopy only to cut and close the gastrointestinal wall.2 These minimally invasive techniques are mainly applied to treatment of gastric submucosal tumors (SMT). In Japan, treatment outcomes for gastric SMT are reported in procedures using laparoscopes such as LECS,1 non-exposed endoscopic wall-inversion surgery (NEWS),3 and combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET).4 Along with this, LECS-related procedures for gastric SMT have been covered by health insurance in Japan since 2014. EFTR was first reported in a porcine model in Japan more than 10 years ago,5 but it has seldom been applied in clinical practice in Japan. In contrast, EFTR for gastric SMT is mainly done in clinical practice in China,2 and treatment outcomes in many cases have been reported. LECS-related procedures are safe and reliable, but it may be too invasive for small gastric SMT. For such lesions, EFTR would be useful as a minimally invasive treatment. However, EFTR still has standardization problems worldwide. In order to clarify the concerns to implement EFTR into Japanese clinical practice, we conducted a questionnaire survey on EFTR for gastric SMT. We herein report the summary of the results and suggest how to improve the procedure to solve the problems. Methods A questionnaire was sent to a panel of endoscopists in leading facilities of therapeutic endoscopy (10 facilities in Japan and one facility in China) who were invited to the upper gastrointestinal session at the Endoscopic Forum Japan (EFJ) 2017. The questionnaires asked about problems in implementing EFTR in clinical practice with open-ended questions rather than closed-ended questions because most Japanese endoscopists still have little experience in carrying out EFTR (Table 1). Based on the results of the questionnaire we examined the current situation and problems of EFTR. Table 1. List of questions in this survey Number Question 1 Please indicate the estimated number of laparoscopic endoscopic cooperative surgery (LECS)-related surgery (LECS, NEWS, CLEAN-NET etc.) cases carried out at your facility. 2 Please indicate the estimated total number of EFTR (by peroral endoscopy only) cases carried out at your facility. 3 What are the potential indications for EFTR? 4 What are the difficulties in carrying out EFTR in clinical practice at present? 5 What are solutions to implement EFTR in clinical practice? 6 What will be future indications for EFTR when it becomes feasible in clinical practice? CLEAN-NET, combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique; EFTR, endoscopic full-thickness resection; NEWS, non-exposed endoscopic wall-inversion surgery. Results Questions 1 and 2: Experience of LECS and EFTR First, we surveyed the experience of LECS and EFTR procedures in questions 1 and 2, respectively (Fig. 1). Figure 1Open in figure viewerPowerPoint Experience of laparoscopic endoscopic cooperative surgery (LECS) (Question 1) and endoscopic full-thickness resection (EFTR) (Question 2). , submucosal tumor (SMT); , cancer. LECS-related procedures had been carried out for gastric SMT in more than 10 cases at each facility. However, LECS-related procedures for early gastric cancer had been done at only five Japanese facilities and the NEWS or CLEAN-NET methods are used. EFTR for gastric SMT had been carried out at only two of the 10 Japanese facilities. In contrast, the one Chinese facility had carried out more than 800 EFTR for patients with gastric SMT. Only one case with local recurrence after ESD underwent EFTR for gastric cancer. Question 3: Potential diseases to be treated by EFTR Regarding the potential diseases (indication) to be treated by EFTR, almost all endoscopists agreed on the indication for EFTR for gastric SMT and gastric cancer with the following features (Table 2). Gastric SMT: lesions 3 cm or smaller in size without ulceration. Gastric cancer: patients who refuse gastric resection, patients in whom ESD is technically difficult as a result of fibrosis, and elderly or poor-surgical-risk patients with localized invasive lesions beyond ESD indication are proposed to be eligible for EFTR. Table 2. Possible indication for EFTR (Question 3) Disease Indication Submucosal tumor (GIST) ≤3 cm No ulceration Retrievable from the mouth Gastric cancer Refusal of gastric resection Technical difficulty of ESD (anastomosis, severe fibrosis etc.) Positive resection margin after ESD Elderly or poor surgical risk patients beyond indication ESD, endoscopic submucosal dissection; GIST, gastrointestinal stromal tumor. Question 4: Difficulties in carrying out EFTR at present Difficulties in the EFTR procedure that were noted by endoscopists were mainly classified into two technical aspects (i.e. excision of the lesion and closure of the defect). (Table 3). Table 3. Difficulty in carrying out endoscopic full-thickness resection (Question 4) Procedure Excision Seromuscular incision in the collapsed stomach after full-thickness resection Maintenance of endoscopic view and traction in the collapsed stomach Reliable hemostatic method for bleeding from serosal vessels Protection of adjacent organ injury in the abdominal cavity Closure Difficulty of complete suturing in the collapsed stomach Unavailability of surgical stapler-like devices Others Prevention of tumor dissemination and infection Not covered by public health insurance Technical difficulties for lesion excision were: (i) maintenance of endoscopic view and achievement of adequate traction after luminal collapses by full-thickness incision; (ii) management of bleeding from thick subserosal vessels; and (iii) protection from injury to adjacent organs etc. Technical difficulties for closure of the luminal defect were: (i) secure and reliable closure for a collapsed gastric wall; and (ii) unavailability of surgical instruments such as a surgical stapler etc. Other difficulties included prevention of peritoneal infection and tumor dissemination during full-thickness resection, and coverage by public insurance etc. Question 5: Solutions that are required to carry out EFTR Solutions to improve the EFTR procedure and implement it in clinical practice were proposed in terms of development of technique and devices. The following solutions for the procedure and devices that need to be developed were proposed (Table 4). Table 4. Solutions to implement EFTR in clinical practice (Question 5) Technical development Quick, reliable, and complete suturing method Application of traction from tumor side Exploration of pure EFTR methods without opening gastric wall Development of method to prevent damage of adjacent organs in the abdominal cavity Device development Clip applicator that can grasp tissue widely and repeat quickly Suturing device for EFTR without opening gastric wall More large twin graspers that rotate freely Large OTSC clip Preoperative diagnostic imaging technology for blood vessels outside the gastric wall Instruments that keep clean the tool that passes the esophagus and stomach and used in the abdominal cavity EFTR, endoscopic full-thickness resection; OTSC, over-the-scope clip. In the technical development: (i) reliable full-layer suturing method; (ii) method to achieve adequate traction for lesion removal and luminal wall tension for suturing; and (iii) full-thickness suturing methods before resection are expected. Regarding device development: (i) clipping devices that can reliably grasp and close the tissue and gastric wall; (ii) a large grasping device that can be used during application of suturing or clipping was proposed. The endoscopists also suggested usefulness of imaging technology that can identify subserosal vessels during the procedure, and a device or a method to keep the abdominal cavity clean during the procedure. Question 6: Future indications for EFTR If the EFTR procedure is to be implemented in clinical practice, the endoscopists believed that the following diseases may be able to be treated with EFTR: gastric cancer that is difficult to remove by ESD technique, gastrojejunal bypass surgery, obesity surgery for reflux esophagitis, early cancer in the diverticulum etc. (Table 5). Table 5. Future indications for EFTR when it becomes feasible in clinical practice Closing of perforation site during ESD Early gastric cancer which is difficult to remove with ESD EFTR for other organ's lesion Stomach-jejunal bypass surgery Sleeve gastrectomy (bariatric surgery) Gastrointestinal stenosis surgery Reflux esophagitis surgery Suturing of artificial ulcer after ESD Early cancer in the diverticulum Resection of esophageal diverticulum etc. EFTR, endoscopic full-thickness resection; ESD, endoscopic submucosal dissection. Discussion Endoscopic full-thickness resection was first reported by Ikeda et al. in 2005 in Japan.5 Thereafter, some experimental studies were reported, but EFTR has not been reported in clinical practice in Japan. In China, Zhou et al. reported clinical application of EFTR for gastric SMT in 2011.2 After that, several reports from multiple Chinese facilities showed a high success rate of the EFTR procedure with a few complication cases that required surgical intervention. This questionnaire survey showed that, currently, in Japan, surgical resection and LECS-related procedures are mostly carried out in patients with gastric SMT. Moreover, LECS-related procedures were even applied for early gastric cancer cases in some Japanese institutions. Meanwhile, EFTR is carried out as almost standard treatment for patients with gastric SMT in the Chinese institution. Reasons for the different prevalence and indication for EFTR between Japan and China may be attributed to the different cultural, social, and ethical backgrounds. In many Chinese institutions, most ESD procedures are carried out under general anesthesia and the clip device (Hemoclips, ROCC-D-26-195-C, Microtech, Nanjin, PRC) that is made in China may be more suitable for closing the defect of the gastric wall. Accordingly, we have to determine suitable indications and settings of EFTR for upper gastrointestinal lesions in Japan. In the questionnaire survey, it was agreed that gastric SMT 3 cm or less in size without ulceration are eligible for EFTR. Recently, with the development of the endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) technique, even small (<2 cm) SMT enable diagnosis of gastrointestinal stromal tumor (GIST).6 At present, LECS-related procedures are standard therapy for patients with small GIST in Japan. In the LECS procedure, tumor resection is carried out from luminal side with peroral flexible endoscopy but it requires an extraluminal maneuver to close the resected luminal defect. Such a maneuver seems to be too invasive for small GIST, especially when the lesion is located in the lesser curvature of the upper body or near the cardia because the lesser omentum that contains gastric arteries and veins and the vagal nerve should be dissected. The EFTR technique for such small GIST is beneficial and is expected to be established as a standard treatment in the future. Among gastric cancers, it was agreed that patients who refuse gastric resection, patients in whom ESD is technically difficult as a result of fibrosis, and elderly or poor-surgical-risk patients with localized invasive lesions beyond ESD indication may be eligible for EFTR. EFTR for such gastric cancers can remove the lesions only without lymph node dissection. However, if EFTR is carried out in conjunction with sentinel node basin dissection, indication for the procedure for gastric cancers may be expanded in the future.7 One of the difficulties of the current EFTR procedure is derived from luminal collapse after full-thickness incision, and how to secure the closure of the luminal defect is a key to improve the EFTR procedure. It is essential to develop devices that solve such difficulties of EFTR in the future. Mori et al. have developed a mechanical traction device to prevent gastric luminal collapse after full-thickness incision,8 and the Double-arm-bar Suturing System as a full-thickness suturing instrument.10 Takizawa et al. have developed a new EFTR technique in the porcine stomach in which the procedure is mainly carried out in the submucosa.10 As the procedures do not open the stomach wall, it is advantageous for avoidance of both bleeding from subserosal vessels and damage to adjacent organs. Although further development of devices is necessary, many clinical studies of EFTR that use currently available ESD devices have already been reported from China. Accordingly, even in Japan, if we set reasonable indications and carefully select patients that fulfil the indication criteria, we must be able to implement EFTR in Japanese clinical practice. If new devices that can solve the problems of the current EFTR procedure are developed in the future, EFTR will also be indicated for other diseases. In the meantime, EFTR could be carried out for small GIST as an investigated trial under general anesthesia with back-up laparoscopy on standby. In summary, this questionnaire survey showed the current situation and problems surrounding the EFTR procedure in Japan in comparison with the Chinese practice. Preparation of optimal setting in collaboration with laparoscopic surgeons and development of new devices are needed to implement EFTR in Japanese clinical practice. Conflicts of Interest Authors declare no conflicts of interest for this article. References 1Hiki N, Yamamoto Y, Fukunaga T et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg. Endosc. 2008; 22: 1729– 35. 2Zhou PH, Yao LQ, Qin XY et al. Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from the muscularis propria. Surg. Endosc. 2011; 25: 2926– 31. 3Goto O, Mitsui T, Fujishiro M et al. New method of endoscopic full-thickness resection: a pilot study of non-exposed endoscopic wall-inversion surgery in an ex vivo porcine model. Gastric Cancer 2011; 14: 183– 7. 4Inoue H, Ikeda H, Hosoya T et al. Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET). Surg. Oncol. Clin. N. Am. 2012; 21: 129– 40. 5Ikeda K, Fritscher-Ravens A, Mosse CA, Mills T, Tajiri H, Swain CP. Endoscopic full-thickness resection with sutured closure in a porcine model. Gastrointest. Endosc. 2005; 62: 122– 9. 6Sekine M, Imaoka H, Mizuno N et al. Clinical course of gastrointestinal stromal tumor diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Dig. Endosc. 2015; 27: 44– 52. 7Goto O, Takeuchi H, Kawakubo H et al. Feasibility of non-exposed endoscopic wall-inversion surgery with sentinel node basin dissection as a new surgical method for early gastric cancer: a porcine survival study. Gastric Cancer 2015; 18: 440– 5. 8Mori H, Rafiq K, Kobara H et al. Innovative noninsufflation EFTR: sufficient endoscopic operative field by mechanical counter traction device. Surg. Endosc. 2013; 27: 3028– 34. 9Mori H, Kobara H, Fujihara S et al. Feasibility of pure EFTR using an innovative new endoscopic suturing device: the Double-arm-bar Suturing System (with video). Surg. Endosc. 2014; 28: 683– 90. 10Takizawa K, Knipschield MA, Gostout CJ. Submucosal endoscopy as an aid to full-thickness resection: pilot study in the porcine stomach. Gastrointest. Endosc. 2015; 81: 450– 4. Citing Literature Volume30, IssueS1Special Issue: Proceedings of the Endoscopy Forum Japan (EFJ), 5-6 August 2017, Grand Park Otaru, Hokkaido, Japan. Guest Editors: Yoshinori Igarashi, Masayuki Kitano and Yutaka Saito. This supplement was published with the support of OLYMPUS CORPORATIONApril 2018Pages 2-6 FiguresReferencesRelatedInformation
What problem does this paper attempt to address?
-
Resection of the Gastric Submucosal Tumor (G-SMT) Originating from the Muscularis Propria Layer: Comparison of Efficacy, Patients' Tolerability, and Clinical Outcomes Between Endoscopic Full-Thickness Resection and Surgical Resection
Liu Sha,Zhou Xinxin,Yao YongXing,Shi Keda,Yu Mosang,Ji Feng
DOI: https://doi.org/10.1007/s00464-019-07311-x
2020-01-01
Abstract:Background and aims Endoscopic full-thickness resection (EFTR) has been increasingly applied in the treatment of gastric submucosal tumors (G-SMTs) with explorative intention. This study aimed to compare the efficacy, tolerability, and clinical outcomes of EFTR and surgical intervention for the management of muscularis propria (MP)-derived G-SMTs. Methods Between September 2011 and May 2019, the clinical records of patients with MP-derived G-SMTs undergoing EFTR at our endoscopic unit were collected. A cohort of people with primary MP-derived G-SMTs treated by surgery was matched in a 1:1 ratio to EFTR group with regard to patients’ baseline characteristics, clinicopathologic features of the tumor and the procedure date. The perioperative outcomes and follow-up data were analyzed. Results In total, 62 and 62 patients were enrolled into the surgery and EFTR group, respectively, with median follow-up of 786 days. The size of G-SMTs (with ulceration) ranged from 10 to 90 mm. For patients with tumor smaller than 30 mm, surgery and EFTR group presented comparable procedural success rate (both were 100%), en bloc resection rate (100% vs. 94.7%), tumor capsule rupture rate (0% vs. 5.3%), and pathological R0 resection rate (both were 100%). EFTR had a statistically significant advantage over surgery for estimated blood loss (3.12 ± 5.20 vs. 46.97 ± 60.73 ml, p ≤ 0.001), discrepancy between the pre- and postprocedural hemoglobin level (5.18 ± 5.43 vs. 9.84 ± 8.25 g/L, p = 0.005), bowel function restoration [1 (0–5) vs. 3 (1–5) days, p ≤ 0.001], and hospital cost (28,617.09 ± 6720.78 vs. 33,963.10 ± 13,454.52 Yuan, p = 0.033). The patients with tumor larger than 30 mm showed roughly the same outcomes after comparison analysis of the two groups. However, the clinical data revealed lower en bloc resection rate (75.0% vs. 100%, p = 0.022) and higher tumor capsule rupture rate (25.0% vs. 0%, p = 0.022) for EFTR when compared to surgery. The procedure time, duration of postprocedural fasting and antibiotics usage, and hospital stay of the two groups were equivalent. The occurrence rate of adverse events within postoperative day 7 were 74.2% and 72.6% after EFTR and surgery, respectively ( p = 1.000). No complications occurred during the follow-up. Conclusion For treatment of MP-derived G-SMTs (with or without ulceration), our study showed the feasibility and safety of EFTR, which also provided better results in terms of procedural blood loss, the postoperative bowel function restoration and cost-effectiveness when compared to surgery, whereas the surgery was superior in en bloc resection rate for G-SMTs larger than 30 mm. The postprocedural clinical outcomes seemed to be equivalent in these two resection methods.
-
Gastric endoscopic submucosal dissection in Western countries: current and future perspective
Yasutoshi Shiratori,Anthony Kalloo
DOI: https://doi.org/10.1055/a-2219-3129
2024-04-25
Endoscopy
Abstract:The multicenter study of gastric endoscopic submucosal dissection (ESD) by Bhandari et al. [1] showed that rates of en bloc resection, R0 resection, and recurrence were 94.7%, 83.4%, and 2.7%, respectively, which were compatible with Japanese data. Notably, this study described long-term results with indication criteria based on the Japanese guidelines (5th edition). We have the following comments and questions. First, the Japanese guidelines (6th edition) [2] have been revised recently based on a multicenter study [3]. Mucosal (T1a) undifferentiated adenocarcinoma <2 cm without ulceration was changed to an absolute indication from the expanded indication. Validity of the new guideline revision should be applied to this European cohort. Next, the authors' outcomes were obtained in a study population in which ESD was completed. However, there may have been cases with incomplete ESD or cases in which ESD was indicated but surgery was performed. It is important to include data on the source population, including all referrals to ESD. Third, the authors' study is based on four experts in high-volume centers. Is this a reflection of how ESD is practiced in Europe? Is ESD only performed in high-volume centers in Europe? How do the authors envisage the training for novice Western endoscopists? Finally, there are significant differences in patient management. In Japan, all patients are hospitalized for 5–7 days [4]. Under inpatient settings, the diet step-up is rigorous, and rebleeding is handled quickly. In addition, in cases with positive horizontal margins, additional ESD can be performed during hospitalization. In contrast, the authors managed patients with overnight observation. In a large US study, 35% of patients underwent ESD as outpatients [5]. These differences may affect outcomes such as rebleeding and delayed perforation rates. As the authors suggested, there is still room to improve the R0 resection rate. In Japan, mapping biopsy is performed before ESD to avoid a positive horizontal margin. Article published online: 23 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
gastroenterology & hepatology,surgery
-
Natural Orifice Endoscopic Surgery (notes) Techniques for Full Thickness R0 Endoscopic Resection of Deep Seated Subepithelial Tumors (sets): First Us Cases
Stavros Stavropoulos,Rani Modayil,Pinghong Zhou,Kumkum Patel,Inna Gulkar,Thomas Coppola,Maurico Zapiach,Collin Brathwaite,David Friedel,James Grendell
DOI: https://doi.org/10.14309/00000434-201310001-02043
2013-01-01
The American Journal of Gastroenterology
Abstract:Purpose: Most UGI SETs are GISTs, potentially malignant tumors. Many guidelines recommend surgery for suspected GISTs ≥2 cm and endoscopic surveillance of those <2 cm. This approach creates a large burden of surgery and endoscopy for small SETs the majority of which are low risk. This situation motivated endoscopists, mostly from Asia, to use ESD to “enucleate” muscularis propria (MP) based SETs. However, such enucleation may leave microscopic residual tumor within the MP. Recently, pioneering Asian centers reported two endoscopic techniques that achieve R0 en bloc resection of MP-based SETs: Submucosal Tunnel Endoscopic Resection (STER)--an offshoot of POEM utilizing the submucosal tunnel method to ensure secure closure of the full-thickness defect in the wall of the GI tract--and endoscopic full-thickness resection (EFTR)-direct full thickness resection with closure of the defect with clips or sutures. We report possibly the first series of EFTR and STER in the U.S. Methods: Procedures were performed from 4/2012-5/2013. Lesion location/size, knives, anesthesia, ASA class, length of procedure, closure technique, histologic diagnosis, adverse events (AEs), and length of stay (LOS) were retrieved from a prospectively maintained database. Results: Fourteen resections (12 EFTRs, 2 STERs) were performed (all procedures but one by one operator, SNS, a gastroenterologist with extensive POEM and ESD experience; one procedure was performed by PZ as part of a live course at our institution). Mean age 61 years (44-83). ASA Class I 14%, II 64%, III 22%. Anesthesia: General 4/14, propofol 10/14. Specialized ESD knives used in all cases (IT2, Hybrid, Hook). SET location: 1 esophagus, 1 GE junction, 10 stomach, 1 sigmoid colon, 1 rectum. 8 GISTs, 4 leiomyomas, 1 schwannoma, 1 leiomyosarcoma. Mean size 25 mm (12-55). Mean resection time 72 minutes (21-170). Closure: endoclips 7/14, endoscopic suturing 4/14, both 3/14. All patients were admitted mainly for observation. Mean LOS 1.8 days (1-3). Complete en bloc resection was achieved in all cases. One minor AE (venting of capnoperitoneum). Conclusion: Unlike traditional ESD, EFTR and STER achieve en bloc R0 resection of moderately sized MP-based SETs. We present the first series of such cases in the U.S. The excellent outcomes probably reflect our extensive experience with POEM, advanced closure techniques, and ESD for SETs. EFTR and STER represent a NOTES alternative to laparoscopic wedge resection. Advantages include: 1. Incisionless approach, 2. “Wedge” resection of SETs at locations where laparoscopic “wedge” resection is challenging or impossible such as the GE junction, esophagus and gastric cardia, and 3. Definitive diagnosis and complete resection obviating any further endoscopic surveillance for low risk lesions. Disclosure - Stavros Stavropoulos ERBE honorarium and Boston Scientific honorarium
-
A Recent Argument for the Use of Endoscopic Submucosal Dissection for Early Gastric Cancers
Waku Hatta,Takuji Gotoda,Tomoyuki Koike,Atsushi Masamune
DOI: https://doi.org/10.5009/gnl19194
IF: 4.321
2020-07-15
Gut and Liver
Abstract:Endoscopic submucosal dissection (ESD) has become the standard treatment method for early gastric cancers (EGCs) due to the negligible risk for lymph node metastasis (LNM) in Eastern Asian countries. According to the guidelines, the curability of EGC after endoscopic resection was classified into three groups: curative resection, expanded curative resection, and noncurative resection. In Eastern Asian countries, a structured follow-up schedule is needed for patients undergoing curative resection and expanded curative resection. Conversely, in Western countries, additional surgery may be recommended for some patients undergoing expanded curative resection (ulcerated, undifferentiated, or slight submucosal invasion) due to the potential risk for LNM, even though specimens of ESD and surgery may not be handled with the same methodology as that used in Japan, which may lead to this slightly higher risk. In noncurative resection, additional surgery is the standard method after ESD because of the risk for LNM. However, in elderly patients and/or those with severe underlying diseases, the advantages and disadvantages of additional surgery should be considered when selecting a post-ESD treatment strategy for patients undergoing noncurative resection. Risk-scoring systems for LNM may facilitate clinical decisions for these patients. However, it should be noted that when recurrence was detected in patients who were followed up with no additional treatment after ESD with noncurative resection, most of them had a poor prognosis. To select an appropriate treatment method, especially in elderly patients undergoing ESD with noncurative resection, a new tool for evaluating the condition of patients should be established.
gastroenterology & hepatology
-
Laparoscopy and Endoscopy Cooperative Surgery for Gastric Tumor.
Ozawa Hiroki,Hirofumi Kawakubo,Shuhei Mayanagi,Kazumasa Fukuda,Osamu Goto,Rieko Nakamura,Koichi Suda,Norihito Wada,Naohisa Yahagi,Yuko Kitagawa
DOI: https://doi.org/10.1200/jco.2018.36.4_suppl.168
IF: 45.3
2018-01-01
Journal of Clinical Oncology
Abstract:168 Background: Laparoscopic wedge resection is widely performed for managing gastric submucosal tumors (SMTs) that measure ≤5 cm in diameter. Laparoscopy and endoscopy cooperative surgery (LECS) is performed to ensure a sufficient margin while avoiding deformation or stenosis. Methods: We conducted a retrospective review of the data of 76 patients who underwent LECS for SMTs or early gastric cancers at our institution between April 2012 and July 2017. While Non-exposed Endoscopic Wall-inversion Surgery (NEWS) was performed for tumors with a major axis diameter of ≤5 cm and minor axis diameter of ≤3 cm, for other tumors, we adopted classical LECS or used the combination of laparoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET). Results: The tumor was located in the upper-/middle-/lower-third of the stomach in 49/20/7 cases. The mean operation time was 201.7 ± 66.2 min, and the mean blood loss was 4.7 ± 12.8 ml. The mean tumor size was 28.6 ± 11.6 mm. The histological tumor types included GIST (n = 38), leiomyoma (n = 14), schwannoma (n = 6), early gastric cancer (n = 8) and others (n = 10). The surgical procedure consisted of classical LECS/CLEAN-NET/NEWS in 17/15/44 cases; all early gastric cancers were treated by NEWS. The mean length of postoperative hospital stay was 8.7 ± 3.9 days. The mean serum levels of C-reactive protein on POD1 and POD3 were 3.2 ± 1.9 and 4.4 ± 3.4 mg/dl, respectively. The postoperative complications were anastomotic stenosis (n = 1), delayed gastric emptying (n = 3), pneumonia (>Grade II by the Clavien-Dindo classification) (n = 1) and exacerbation of GERD (>Grade II by the Clavien-Dindo classification) (n = 3). In the patient group that developed complications, the postoperative resumption of water intake was later, and the postoperative hospital stay was longer as compared to the group without complications (p = 0.04, 0.028). No relationship was observed between the likelihood of development of complications and the tumor location. Conclusions: Use of minimally invasive surgical procedures such as LECS could minimize the extent of gastric resection without deformation, stenosis. We consider that for surgical complications the LECS approach can be employed, regardless of the tumor location.
-
Feasibility and safety of endoscopic full‐thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video)
Yingjie Guo,Fan Yin,Xingsi Qi,Peng Zhang,Xueguo Sun,Xueli Ding,Xiaoyu Li,Xue Jing,Yueping Jiang,Zibin Tian,Tao Mao
DOI: https://doi.org/10.1111/den.14918
2024-09-11
Digestive Endoscopy
Abstract:Objectives Endoscopic full‐thickness resection (EFTR) for submucosal tumors (SMTs) has been technically challenging. This retrospective study aimed to evaluate the feasibility, safety, and efficacy of EFTR for upper gastrointestinal (GI) SMTs, including extraluminal lesions. Methods We retrospectively investigated 232 patients with SMTs who underwent EFTR from January 2014 to August 2023. Clinicopathologic characteristics, procedure‐related parameters, adverse events (AEs), and follow‐up outcomes were assessed in all patients. Results The en‐bloc resection and en‐bloc with R0 resection rates were 98.7% and 96.1%, respectively. The average endoscopic tumor size measured 17.2 ± 8.7 mm, ranging from 6 to 50 mm. The resection time and suture time were 49.0 ± 19.4 min and 22.5 ± 11.6 min, respectively. In all, 39 lesions (16.8%) exhibited predominantly extraluminal growth. Gastrointestinal stromal tumors (GISTs) were the predominant pathology, accounting for 78.4% of the cases. Twenty‐one patients (9.1%) encountered complications, including pneumothorax (1/232, 0.43%), hydrothorax (1/232, 0.43%), localized peritonitis (3/232, 1.29%), and fever (16/232, 6.9%). Although the incidence of postoperative fever was notably higher in the predominantly extraluminal group (7/39, 17.9%) compared to the predominantly intraluminal group (9/193, 4.7%, P = 0.008), there were no significant differences in outcomes of the EFTR procedure. No instances of recurrence were observed during the mean follow‐up period of 3.7 ± 2.3 years. Conclusion EFTR was found to be feasible, safe, and effective for resecting upper GI SMTs, including lesions with predominantly extraluminal growth. Further validation in a prospective study is warranted.
gastroenterology & hepatology,surgery
-
A129 OUTCOMES FOLLOWING ENDOSCOPIC SUBMUCOSAL DISSECTION OF SUPERFICIAL GASTROINTESTINAL TRACT NEOPLASTIC LESIONS FROM A TERTIARY-CARE ACADEMIC CENTRE
S Gupta,F Dang,Y Fujiyoshi,S Li,K Khalaf,G May,J Mosko,C Teshima
DOI: https://doi.org/10.1093/jcag/gwad061.129
2024-02-14
Journal of the Canadian Association of Gastroenterology
Abstract:Abstract Background Endoscopic submucosal dissection (ESD) is an advanced luminal resection technique for dysplastic and early cancerous gastrointestinal (GI) tract neoplasms. By removing lesions en bloc, this method provides more accurate histopathologic evaluation of resection margins in comparison to endoscopic mucosal resection (EMR). Superior curative resection and lower recurrence rates over EMR have been shown in addition to the benefit of reduced morbidity and mortality compared to surgery. While ESD has become well-established in Asia and Europe, its adoption in North America – and in particular Canada – has been slowed by multiple technical and economic factors including a scarcity of infrastructure, institutional support, and standardized training. Additionally, reproduced Canadian data corroborating its known global efficacy is currently lacking. Aims Our aim was to evaluate clinical and technical outcomes in patients who underwent ESD of superficial GI tract neoplasms at a tertiary-care academic centre. Methods We conducted a retrospective single-centre cohort study at The Centre for Advanced Therapeutic Endoscopy & Endoscopic Oncology, St. Michael’s Hospital, Toronto, Canada. Consecutive adults (age ampersand:003E 18) who underwent ESD of any superficial GI tract neoplasm from October 2017 to December 2022 were included in the study. Primary outcomes were rates of en bloc, complete (R0), and curative resections. Secondary outcomes were rates of recurrence and adverse events. Data was collected through electronic chart review. Results ESD was performed in a total of 308 lesions with a mean size of 2.5 cm (range, 1-7 cm). Gastric ESD was the most common (n=130), followed by esophageal (n=91), rectal (n=62), and colonic (n=22). Three patients underwent duodenal ESD. En bloc, R0, and curative resection rates were 89.2%, 84.7%, and 71.8%, respectively. 64.3% of lesions were cancerous on pathology (n=198), of which 48 had at least submucosal invasion. Rates of delayed bleeding and deep mural injury (DMI) requiring surgical intervention were 3.9% and 1.3%, respectively. Overall recurrence at the first surveillance endoscopy (SE1) was 3.6%. Conclusions En bloc, R0, and curative resection rates reported from this largest single-centre Canadian ESD cohort are comparable to existing North American data. Low rates of early recurrence and an adequate safety profile have been demonstrated with this emerging oncologic method of resection. Additional investigation is warranted to optimize lesion selection and determine long-term clinical outcomes to further establish this technique in the management of superficial GI tract neoplasms. Table I. Procedural characteristics, outcomes, and adverse events for patients who underwent ESD of superficial GI tract neoplasms. Funding Agencies None
-
Su1294 FEASIBILITY AND EFFICACY OF NON-EXPOSED ENDOSCOPIC WALL-INVERSION SURGERY (NEWS): A RETROSPECTIVE ANALYSIS IN 50 GASTRIC LESIONS
Osamu Goto,Hirofumi Kawakubo,Teppei Akimoto,Atsushi Nakayama,Ai Fujimoto,Yasutoshi Ochiai,Tadateru Maehata,Motohiko Kato,Yuko Kitagawa,Naohisa Yahagi
DOI: https://doi.org/10.1016/j.gie.2018.04.1681
IF: 10.396
2018-01-01
Gastrointestinal Endoscopy
Abstract:In endoscopic full-thickness resection with or without laparoscopic assistance, intentional perforation of the gastric wall which is unavoidable during the procedure may cause bacterial contamination as well as tumor-cell seeding particularly in ulcerated submucosal tumors (SMTs) or cancers. To avoid these risks, we have developed a non-exposure technique of laparoscopy-assisted endoscopic full-thickness resection, called non-exposed endoscopic wall-inversion surgery (NEWS). In this study, we retrospectively investigated the feasibility and efficacy of NEWS for gastric SMTs. Indication of NEWS included intraluminal or intramural growth-type gastric SMTs that were clinically diagnosed as gastrointestinal stromal tumors ≤3 cm in size, regardless of the existence of ulcerative findings; or cT1N0 single early gastric cancers (EGCs) ≤4 cm in size, except for an absolute indication for endoscopic resection (cT1aN0 intestinal-type, ≤2 cm). NEWS was performed as follows: laparoscopic sero-muscular incision after endoscopic submucosal injection, laparoscopic sero-muscular suturing with the lesion inverted, endoscopic muco-submucosal incision, and transoral retrieval. In EGCs, sentinel node navigation surgery was combined by using RI and indocyanine green injection. If stained sentinel nodes (SNs) had no metastasis by intraoperative histological assessment, NEWS with sentinel node basin dissection was conducted. The feasibility and efficacy of this technique was investigated by assessing short and middle term outcomes. NEWS was performed in 50 cases, including 41 SMTs and 9 EGCs between August 2013 and November 2017. The mean tumor size was 23.6 mm. In all cases, the procedure was completed in a mean procedural time of 202.6 min in SMT cases and 304.0 min in EGC cases, respectively, with 1 intraoperative perforation (2.0%). Final histological diagnoses were gastrointestinal stromal tumor (23), gastric cancer (8), leiomyoma (5), ectopic pancreas (5), neurinoma (3), no residual cancer after endoscopic resection (1), and others (5). R0 resection rate in 39 tumors was 97.4%. The mean discharge duration was 7.6 days following treatment. During the mean observational period of 24.5 months, overall and disease-free survival rates were 98% and 100%, respectively. In 1 EGC case who underwent NEWS with left gastric artery basin dissection, severe stasis because of adhesion to the peritoneum occurred, which required distal gastrectomy on the postoperative day 77. NEWS for gastric SMTs and EGCs appeared to be both feasible and safe. This non-exposed full-thickness resection technique by collaborative use of endoscopy and laparoscopy may be a useful option for minimally invasive local resection even for ulcerated SMTs or cancers without risk of tumor cell seeding due to the intentional perforation of the gastric wall.
-
CURRENT SITUATION OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL NEOPLASMS IN THE UPPER DIGESTIVE TRACT IN EAST ASIAN COUNTRIES: A QUESTIONNAIRE SURVEY
Noriya Uedo,Hwoon-Yong Jung,Mitsuhiro Fujishiro,I-Lin Lee,Ping-Hong Zhou,Philip Wai Yan Chiu,Dong Kyung Chang,Kenichi Goda
DOI: https://doi.org/10.1111/j.1443-1661.2012.01281.x
2012-01-01
Digestive Endoscopy
Abstract:Aim: This study was carried out to understand the current practice and learning of endoscopic submucosal dissection (ESD) for superficial esophageal and gastric cancers in East Asian countries.Methods: A questionnaire survey was used to investigate differences in upper gastrointestinal (GI) ESD among East Asian countries.Results: ESD is used by many endoscopists in not only tertiary centers but also secondary care hospitals in China, Korea and Japan. By contrast, it is less used by doctors in tertiary centers in Hong Kong and Taiwan. However, the general trend appears to be the same; ESD, which is a highly advanced endoscopic technique, is being transmitted from preceptors to preceptees in tertiary centers, then from doctors in tertiary centers to experienced doctors in secondary hospitals. The speed of learning and uptake in the practice of this procedure will depend on the volume of cases. Upper GI ESD can be expected to spread at a similar rate across different districts or hospitals in East Asia because of similarities in disease prevalence. Also, endoscopists in this region can easily learn from each other by attending international conferences or visiting endoscopy units to learn the procedure.Conclusion: Efforts to establish a standardized protocol for ESD practice and training are important, and may help endoscopists around the world develop this technique further.
-
Application of Endoscopic Submucosal Dissection (ESD) in Treatment of Gastrointestinal Lesions-Single Center Experience
Wojciech Ciesielski,Tomasz Klimczak,Adam Durczyński,Piotr Hogendorf,Janusz Strzelczyk
DOI: https://doi.org/10.1089/lap.2024.0083
Abstract:Background and Objectives: Endoscopic resection of gastrointestinal (GI) tract lesions, originating from Japan, is becoming more frequently used in European countries. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) ensure minimally invasive removal of benign, premalignant, and early neoplastic tumors of esophagus, stomach, and intestine in selected group of patients. Aim of this study was to determine the outcomes, radical resection rate (R0), and complication rate of ESD procedures performed in our department. Methods: The data from 100 ESD procedures of esophageal, gastric, duodenal, and colorectal lesions performed in out unit between 02.01.2020 and 30.06.2023 were collected and analyzed retrospectively. Results: A total of 42 male and 58 female patients in the median age of 64 years (range, 31-89 years) underwent ESD. Mean duration of the procedure was 66 minutes (ranging 25-185 minutes). Tumors were located in the esophagus in 8 cases (8%), stomach in 25 cases (25%), duodenum in 1 case (1%), and colon in 66 cases (66%). Radical resection was achieved in 98 cases (98%); 2 patients were qualified for surgical treatment. Average size of dissection lesions was 26 × 19 mm. The biggest one was 60 × 60 mm (sigmoid adenoma), and the smallest one was 5 × 5 mm (gastrointestinal neuroectodermal tumors). Complication occurred in 10 patients (10%)-9 perforations of the wall of intestine (9%) and 1 hemorrhage, which required endoscopic intervention (1%). Conclusions: Implementation of ESD to clinical practice gives the opportunity for minimally invasive, radical treatment of benign, premalignant, and early neoplastic lesions of gastrointestinal tract in selected group of patients. Experienced endoscopists, following current guidelines and standardized process of qualification, are crucial to minimize the risk of severe complications.
-
Outcomes of endoscopic submucosal dissection of early gastric cancer neoplasia in the West and change in the absolute indications
Glòria Fernández-Esparrach,José C. Marín-Gabriel
DOI: https://doi.org/10.1055/a-2215-5644
2024-04-25
Endoscopy
Abstract:Bhandari et al. [1] reported the long-term outcomes of 415 gastric endoscopic submucosal dissection (ESD) cases and confirmed that the procedure is safe and effective in a Western setting. Rates of en bloc and R0 resection, and recurrence were 94.7%, 83.4%, and 2.7%, respectively. Perforation, early and delayed bleeding occurred in 2.4%, 4.3%, and 3.4%, respectively. This is the largest Western multicenter cohort but not the only one. A North American multicenter study with 347 gastric ESDs reported rates of en bloc and R0 resection, and recurrence of 92%, 82%, and 3.9%, respectively [2]. Another Italian multicenter study with 299 cases reported en bloc and R0 rates of 97.6% and 89%, respectively [3]. In Spain, the results from the national prospective registry with 230 gastric ESDs showed en bloc and R0 rates of 91.3% and 75.2%, respectively [4]. This could be explained by the fact that ESDs were performed by 30 endoscopists, many of whom were at the beginning of their learning curve. Moreover, difficult ESD (en bloc resection not achieved, hybrid resection, procedure duration >2 hours, or intraprocedural perforation) had lower R0 resection rates than ESDs not classified as difficult (64.8% and 87.6%, respectively; P = 0.000) [4]. What is new in the study by Bhandari et al. [1] is that the authors used the absolute indications for ESD published in 2021, which included the former expanded indications but without T1a undifferentiated-type adenocarcinoma of ≤2 cm without ulcerative findings. More recently, in the 6th edition of the Japanese gastric cancer treatment guidelines published in 2023 [5], only locally recurring lesions are considered as the expanded indication. In conclusion, the implementation of gastric ESD in Western countries is a reality. To achieve similar outcomes to those in Asian countries, it should be performed by well-trained endoscopists. New studies are needed to confirm the outcomes of new absolute indications for gastric ESD outside of Japan. Article published online: 23 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
gastroenterology & hepatology,surgery
-
Safety and efficacy of a modified endoscopic full-thickness resection technique for gastric submucosal tumors: a case series
Yingsheng Zhou,Yan Huang,Wen Cheng,Jiamin Wang,Xiaoqiang Liu,Huan Peng,Juan Zhang,Qiaoqun Feng
DOI: https://doi.org/10.3389/fonc.2024.1403517
2024-07-09
Abstract:Objectives: Endoscopic full-thickness resection (EFTR) has proven effective and economical for patients with gastric submucosal tumors (SMTs). However, the poor operative field of view, the risk of massive hemorrhage, and the difficulties in defect closure have limited its widespread application. Herein, we described a modified EFTR technique developed to simplify the dissection and defect closure procedures using common and economical endoscopic accessories. Methods: Forty-two patients who underwent the modified EFTR for gastric SMTs in the Shenzhen Guangming District People's Hospital were enrolled in the case series. Following a cross incision to expose the intraluminal surface the tumors were captured by suction through a transparent cap and the roots were ligated using a loop. The tumors and part of the suction tissue were removed along the ligated root. A tension-relieving closure was performed by clipping the raised plica in four quadrants outside the ligated root. Patient demographics, tumor characteristics, and therapeutic outcomes were evaluated retrospectively. Results: All tumors had an R0 resection. The median procedure time was 51.8 min (IQR 34.25 min). No severe perioperative adverse events occurred. No residual lesion or recurrence was reported during the follow-up period of 9.84 months (IQR 5.0 months). Conclusion: The safety and practicability of Modified-EFTR could allow for wide clinical application in patients with micro-gastric SMTs.
-
Colorectal Endoscopic Submucosal Dissection: An Update on Best Practice
Tara Keihanian,Mohamed O Othman
DOI: https://doi.org/10.2147/CEG.S249869
2021-08-03
Clinical and Experimental Gastroenterology
Abstract:Tara Keihanian, 1 Mohamed O Othman 2 1 Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, USA; 2 Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, USA Correspondence: Mohamed O Othman Gastroenterology and Hepatology Section, Baylor College of Medicine, 7200 Cambridge St., 8th Floor, Suite 8B, Houston, TX, 77030, USA Email Endoscopic submucosal dissection (ESD) is a method of en-bloc resection of neoplastic colorectal lesions which is less invasive compared to surgical resection. Lesion stratification, architecture recognition and estimation of depth of invasion are crucial for patient selection. Expert endoscopists have integrated a variety of classification systems including Paris, lateral spreading tumor (LST), narrow band imaging (NBI), international colorectal endoscopic (NICE) and Japanese NBI expert team (JNET) in their day-to-day practice to enhance lesion detection accuracy. Major societies recommend ESD for LST-non granular (NG), Kudo-VI type, large depressed and protruded colonic lesions with shallow submucosal invasion. Chance of submucosal invasion enhances with increased depth as well as tumor location and size. In comparison to endoscopic mucosal resection (EMR), ESD has a lowerl recurrence rate and higher curative resection rate, making it superior for larger colonic lesions management. Major complications such as bleeding and perforation could be seen in up to 11% and 16% of patients, respectively. In major Western countries, performing ESD is challenging due to limited number of expert providers, lack of insurance coverage, and unique patient characteristics such as higher BMI and higher percentage of previously manipulated lesions. Keywords: endoscopic submucosal dissection, colonic neoplasm, endoscopic mucosal resection Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are two methods for the removal of pre-malignant and early malignant colonic lesions. EMR is usually not successful for en-bloc removal of lesions greater than 20 mm in diameter; piecemeal resection of larger lesions has been shown to correlate with a higher recurrence rate in comparison to ESD. 1 Conventional EMRs usually result in endoscopic piecemeal mucosal resection of large lateral spreading tumors ≥20 mm, with reports of local recurrence rates ranging from 7.4 to 17%. 2 The concept of ESD was first introduced in the late 1990s for en-bloc removal of superficial gastric malignancies in Japan. 2 Considering the greater recurrence rate of larger lesions after EMR, ESD is preferred for lesions with limited submucosal invasion and particularly if the lesions are larger than 30 mm. 3 ESD allows for exact histopathological evaluation of the specimen margin, enhancing its utility and avoiding further unnecessary surgical interventions. The adoption of ESD worldwide for the treatment of early-stage colorectal cancers promoted various societies and gastrointestinal associations to publish guidelines and recommendations to standardize the practice. One of the first updated guidelines was released by the Japanese Gastroenterological Endoscopy Society (JGES) in 2015. According to the JGES, indications for ESD include: 4 The European Society of Gastrointestinal Endoscopy (ESGE) also released their recommendations on the same year, focusing on ESD application in Western populations. Their recommendations were similar to the JGES guideline, advising ESD for colorectal lesions with depressed morphology and irregular or nongranular surface pattern, particularly if the lesions are larger than 20 mm 3 . The guideline still referred to surgery for gold standard treatment for lesions IIa + c, IIc, III, non-lifting lesions, or LST-NG > 20mm, with the exception of rectal lesions, however. 3 Most recently, the American Gastroenterology Association (AGA) clinical practice update was released in 2019, recommending ESD for colonic lesions with Kudo V-type pit pattern, depressed component (Paris 0–IIc), complex morphology (0–Is or 0–IIa+Is), rectosigmoid location, nongranular LST (adenomas) 20 mm in size, granular LST (adenomas) > or =30 mm in size, and residual or recurrent colorectal adenomas. 5 For lesions with unfavorable features after resection, further surgical intervention might be necessary. The most recently published Korean practice guideline, 2020, similar to the Japanese clinical guideline in 2015, acknowledged that the presence of poor histopathological types (poorly differentiated adenocarcinoma, signet ring cell carcinoma, mucinous carc -Abstract Truncated-
-
Endoscopic full-thickness resection: circumferential cutting method
Keiichi Ikeda,C Alexander Mosse,Per-Ola Park,Annette Fritscher-Ravens,Maria Bergström,Tim Mills,Hisao Tajiri,C Paul Swain
DOI: https://doi.org/10.1016/j.gie.2005.12.039
Abstract:Background: Endoscopic full-thickness resection (EFTR) at flexible endoscopy might allow less-invasive removal of more deeply penetrating cancers that have not spread to the serosal surface and more complete histologic examination of the excised tissue. Objective: A method for closure of full-thickness defects in the stomach wall would be valuable for other endosurgical applications. Setting: A method that uses an end cap and band-ligation without prior injection of saline solution to perform EFTR gave good results and was safe in pig studies. There is a size limitation of cancers that can be resected en bloc when using this method. The depth of resection was also variable. Design and interventions: EFTR was achieved by circumferential cutting with a sphincterotome and a snare. A prototype bidirectional cutter was tested. Sutured closure was accomplished by using a sheathed needle, a metal tag, and a thread at the tip, passed through a 2.8-mm accessory channel. Knot-tying devices secured the sutured defect. Main outcome measurements: EFTR was studied in non-survival (n = 4) and survival (n = 8) experiments in pigs. Results: Full-thickness specimens were resected from the gastric wall (100%, 12/12), and the defects were closed by using sewing and knot-tying devices (100%, 12/12). Limitations: A healing ulcer at the suturing site was evident at follow-up endoscopy in the survival experiments. Bleeding, which was stopped by suturing, occurred in 1 pig (8.3%, 1/12). All pigs survived these experiments without complications (100%, 8/8). Conclusions: Circumferential EFTR was feasible and appeared safe in survival experiments. This method might allow larger and deeper resection of tumors in the gastric wall.
-
Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from muscularis propria layer
Ping-hong Zhou,Li-qing Yao,Xin-yu Qin,Mei-dong Xu,Yun-shi Zhong,Li-li Ma,Yi-qun Zhang,Wei-feng Chen,Wen-zheng Qin,Jian-wei Hu,Ming-yan Cai,Jing-zheng Liu
DOI: https://doi.org/10.3760/CMA.J.ISSN.1007-5232.2009.12.001
2009-01-01
Abstract:Objective To evaluate the feasibility and efficacy of endoscopic full-thickness resection (EFR) without laparoscopic assistance for gastric submucosal tumors (SMTs) originated from muscularis propria layer. Methods A total of 20 cases of gastric SMT, originated from muscularis propria, was resected by EFR from July 2007 to August 2009. EFR consisted of five major procedures, including normal saline injection into the submncosa and pre-cut of the mucosal and submucosal layer around the lesion, circumferential incision as deep as muscularis propria around the lesion with endoscopic submucosal dissection (ESD) , incision into serosal layer around the lesion with a Hook knife, full-thickness recection of the tumor including the serosal layer with Hook, IT, or snare on gastroscopy without laparoscopic assistance and closure of the gastric wall with metallic clips. Results Of 20 gastric SMTs, 9 located at the fundus, 11 at the corpus. EFR was successfully performed in all 20 patients without laparoscopic assistance. The complete resection rate was 100% , and the mean operation time was 85 min (60-145 min). The mean tumor size was 2. 6 cm ( 1.8-3.5 cm). Pathological examination confirmed gastrointestinal stromal tumors (GISTs) in 13 cases, leiomyoma in 4, glomus tumor in 2 and Schwannoma in 1 patient. No gastric bleeding, peritonitis or abdominal abscess occurred after EFR. Post-operative contrast roentgenography on the third day detected no contrast extravasation into abdominal cavity or disturbance of gastric emptying in any patients. The mean hospitalization time was 5.5 d (3-8 days). The mean follow-up period was 7 months ( 1-12 months) with no lesion residue or recurrence. Conclusion EFR, efficacious, safe, and minimally invasive for patients with gastric SMTs originated from muscularis propria layer, is able to resect deep gastric lesion and provide precise path- ological information about the lesion. With the development of EFR, the indication of endoscopic resection might be extended.\r\n\r\nKey words: \r\nEndoscopic surgical procedures; Stomach; Submucosal tumor; Endoscopic fullthickness resection
-
Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video)
David J Tate,Amir Klein,Mayenaaz Sidhu,Lobke Desomer,Halim Awadie,Eric Y T Lee,Hema Mahajan,Duncan McLeod,Michael J Bourke
DOI: https://doi.org/10.1016/j.gie.2019.04.242
Abstract:Background and aims: Endoscopic submucosal dissection (ESD) is an effective, minimally invasive, surgery-sparing technique for the treatment of early gastric cancer (EGC). It is not well established whether EGC within the Japanese expanded criteria can be safely and effectively treated using ESD in the West. We describe the outcomes of ESD for endoscopically suspected, biopsy specimen-confirmed EGC and its adenomatous precursor lesions (pEGC) using the Vienna classification of dysplasia in a Western cohort. Methods: Prospective data were collected on all pEGCs undergoing ESD at a single expert endoscopy center. Outcomes were compared among pEGC, satisfying the Japanese absolute and expanded criteria, those outside criteria, and those specimens that contained low-grade dysplasia (LGD) only. Specialist GI pathologists reviewed and classified all ESD specimens. Patients were followed up at 6 and 12 months. Results: Over 71 months, 135 pEGCs in 121 patients (mean age, 72.0 years; 61.2% men) underwent ESD. Median pEGC size was 20 mm (interquartile range, 15-30), and 62 (45.9%) satisfied the expanded clinical criteria. Perforation occurred in 1.5% and postprocedural bleeding in 5.2%. Forty-two pEGCs (31.1%) contained LGD only. Rates of en bloc and R0 resection were 94.8% and 86.7%, respectively. One hundred seven pEGCs (79.2%) met the absolute or expanded criteria for endoscopic cure. Two pEGCs recurred during follow-up. Ten of 26 patients with pEGC (38.5%) outside criteria for cure underwent surgery after ESD with residual tumor detected in 3 specimens. Fifteen patients with outside criteria for pEGCs did not undergo surgery because of frailty or their expressed wish. Eleven of 15 patients have so far undergone first surveillance with 1 of 11 experiencing endoscopic and histologic recurrence. Conclusions: ESD is a safe and effective treatment for pEGCs in a Western context. Patients who either decline or are too frail for surgery, with outside criteria resections, may benefit from ESD for local disease control. Large Western studies of ESD for pEGCs are required to define long-term patient outcomes and surveillance guidelines, particularly where pathology shows LGD or high-grade dysplasia only. (Clinical trial registration number: NCT02306707.).
-
Cutting-Edge Technologies for Gastrointestinal Therapeutic Endoscopy
Osamu Goto,Eriko Koizumi,Kazutoshi Higuchi,Hiroto Noda,Takeshi Onda,Jun Omori,Mitsuru Kaise,Katsuhiko Iwakiri
DOI: https://doi.org/10.1272/jnms.jnms.2021_88-109
2021-01-01
Journal of Nippon Medical School
Abstract:With advancements in the development of flexible endoscopes and endoscopic devices and the increased demand for minimally invasive treatments, the indications of therapeutic endoscopy have been expanded. Methods of endoscopic treatment used for tissue removal, hemostasis, and dilatation are as follows. Endoscopic submucosal dissection (ESD) is considered the gold standard curative method for removal of gastrointestinal node-negative neoplasms, regardless of their size or the presence of ulcer formation. Laparoscopic endoscopic cooperative surgery (LECS), which incorporates ESD, was introduced for removal of lesions in deeper layers. Another technique is endoscopic full-thickness resection, which is challenging without the assistance of laparoscopy. In terms of hemostasis, management of iatrogenic bleeding after endoscopic treatment is an important issue. Shielding methods and suturing techniques have been introduced for large mucosal defects after ESD, and their efficacy has been investigated clinically. Peroral endoscopic myotomy (POEM) is a new alternative surgical approach for minimally invasive treatment of esophageal achalasia. Furthermore, endoscopic fundoplication after POEM was devised to prevent post-POEM gastroesophageal reflux disease. Many endoscopic treatments, including ESD, LECS, and POEM, have been introduced in Japan. With the aging of the population, more attention will be directed toward therapeutic endoscopy for elderly patients, because it is less invasive. Development of endoscopic treatments with expanded indications is expected.
-
Recent developments in gastric endoscopic submucosal dissection: Towards the era of endoscopic resection of layers deeper than the submucosa
Nobutsugu Abe,Hirohisa Takeuchi,Atsuko Ooki,Gen Nagao,Tadahiko Masaki,Toshiyuki Mori,Masanori Sugiyama
DOI: https://doi.org/10.1111/j.1443-1661.2012.01387.x
2013-01-24
Digestive Endoscopy
Abstract:With technical advances in endoscopic submucosal dissection (ESD), several variations of endoscopic procedure derived from ESD and fusion procedures of endoscopy and laparoscopy for upper gastrointestinal submucosal tumor and cancer have recently been developed. The former includes endoscopic muscularis dissection (EMD), submucosal endoscopic tumor resection (SET), endoscopic submucosal tunnel dissection (ESTD) and endoscopic full-thickness resection (EFTR), and the latter includes laparoscopic and endoscopic cooperative surgery (LECS), laparoscopy-assisted endoscopic full-thickness resection (LAEFR), and laparoscopic lymphadenectomy without gastrectomy following ESD. In the present article, recent developments in gastric ESD and advanced procedures derived from ESD are discussed.
gastroenterology & hepatology,surgery
-
Endoscopic Full-Thickness Resection (EFTR) Without Laparoscopic Assistance for Nonampullary Duodenal Subepithelial Lesions: Our Clinical Experience of 32 Cases
Zhong Ren,Sheng-Li Lin,Ping-Hong Zhou,Shi-Lun Cai,Zhi-Peng Qi,Jian Li,Li-Qing Yao
DOI: https://doi.org/10.1007/s00464-018-06644-3
2019-01-01
Surgical Endoscopy
Abstract:BACKGROUND:Standard treatment for nonampullary duodenal tumors has not yet been established. In case of tumors originated from the muscularis propria (MP) layer and adherent to the serosa layer, the lesions can not be completely removed by ESD. However, with the development of the endoscopic suture technique, endoscopic full-thickness resection (EFTR) of duodenal subepithelial lesions has become possible.METHODS:We retrospectively analyzed 32 patients with nonampullary duodenal subepithelial lesions who underwent EFTR between February 2012 and January 2017. The suturing method, complications that occurred during and after the operations, perioperative management, tumor characteristics, and pathological findings were analyzed in all patients.RESULTS:The complete resection rate was 100%; all patients successfully received EFTR except for one patient who required conversion to open surgery. Severe abdominal pain was observed after the operation in one patient who then received laparoscopic exploration, and the possibility of delayed perforation was considered. Another patient showed a decline in blood oxygen saturation (SO2) and was transferred to the intensive care unit (ICU) for further management. Delayed bleeding and fistula were not observed. All patients achieved complete remission.CONCLUSION:EFTR is a safe, minimally invasive treatment modality that ensures complete eradication of the duodenal subepithelial lesions.
-
Current status of colorectal endoscopic submucosal dissection in Japan and other Asian countries: progressing towards technical standardization.
Yutaka Saito,Hiroshi Kawano,Yoji Takeuchi,Ken Ohata,Shiro Oka,Kinichi Hotta,Koichi Okamoto,Kiyoaki Homma,Toshio Uraoka,Takashi Hisabe,Dong Kyung Chang,Ping-Hong Zhou
DOI: https://doi.org/10.1111/j.1443-1661.2012.01282.x
2012-01-01
Digestive Endoscopy
Abstract:Aim: The primary purpose of this questionnaire survey study was to determine the current status of colorectal endoscopic submucosal dissection (ESD) in specialized Japanese referral centers before and after introduction of a government-approved advanced medical treatment system; and, secondly, to determine the current status of colorectal ESD in other Asian specialized referral centers. Methods: A total of 1321 colorectal ESDs were performed in 11 institutions including two Asian centers outside Japan. Results: Overall en-bloc resection, curative resection, R0 resection, perforation, delayed bleeding and emergency surgery rates were 95.4%, 89.1%, 87.2%, 2.9%, 2.5% and 0.2%, respectively. Similar clinical results were reported in the two Asian centers. Conclusion: There were no significant differences with regards to clinical results between the two periods although the perforation rate decreased from 3.3% to 2.4%. In addition, colorectal ESD has become increasingly standardized technically at specialized referral centers not only in Japan, but several other Asian referral institutions as well.